ATE331958T1 - Verfahren zum nachweis und zur quantifizierung von -aus soliden tumoren abstammenden- zirkulierenden tumorzellen - Google Patents

Verfahren zum nachweis und zur quantifizierung von -aus soliden tumoren abstammenden- zirkulierenden tumorzellen

Info

Publication number
ATE331958T1
ATE331958T1 AT03743923T AT03743923T ATE331958T1 AT E331958 T1 ATE331958 T1 AT E331958T1 AT 03743923 T AT03743923 T AT 03743923T AT 03743923 T AT03743923 T AT 03743923T AT E331958 T1 ATE331958 T1 AT E331958T1
Authority
AT
Austria
Prior art keywords
cells
tumour
culture surface
tumour markers
specific
Prior art date
Application number
AT03743923T
Other languages
English (en)
Inventor
Jean-Pierre Vendrell
Catherine Panabieres
Genevieve Choquet-Kastylevsky
Michel Jolivet
Original Assignee
Biomerieux Sa
Chu Montpellier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomerieux Sa, Chu Montpellier filed Critical Biomerieux Sa
Application granted granted Critical
Publication of ATE331958T1 publication Critical patent/ATE331958T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT03743923T 2002-03-13 2003-03-13 Verfahren zum nachweis und zur quantifizierung von -aus soliden tumoren abstammenden- zirkulierenden tumorzellen ATE331958T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0203136 2002-03-13

Publications (1)

Publication Number Publication Date
ATE331958T1 true ATE331958T1 (de) 2006-07-15

Family

ID=27799043

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03743923T ATE331958T1 (de) 2002-03-13 2003-03-13 Verfahren zum nachweis und zur quantifizierung von -aus soliden tumoren abstammenden- zirkulierenden tumorzellen

Country Status (8)

Country Link
US (1) US20050079557A1 (de)
EP (1) EP1506407B1 (de)
JP (1) JP4256265B2 (de)
AT (1) ATE331958T1 (de)
AU (1) AU2003242815A1 (de)
DE (1) DE60306517T2 (de)
ES (1) ES2268387T3 (de)
WO (1) WO2003076942A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2846426B1 (fr) 2002-10-28 2004-12-10 Bio Merieux Procede de dosage du ngf pour le diagnostic in vitro du cancer du sein et utilisation en therapie
EP1723428A2 (de) 2004-02-19 2006-11-22 Yale University Corporation Identifizierung von krebsprotein-biomarkern unter verwendung von proteomtechniken
PL1861509T3 (pl) * 2005-03-14 2016-01-29 Janssen Diagnostics Llc Sposób predykcji przeżywalności bez progresji i przeżywalności całkowitej przy wizytach kontrolnych w trakcie terapii u pacjentów z rozsianym rakiem piersi wykorzystujący krążące komórki nowotworowe
FR2896881B1 (fr) 2006-01-31 2008-04-18 Biomerieux Sa Procede de dosage du prongf pour le diagnostic in vitro du cancer du sein et utilisation du prongf en therapie
WO2007106545A2 (en) * 2006-03-13 2007-09-20 Veridex, Llc Propagation of primary cells
EP2064552B1 (de) * 2006-09-07 2011-08-31 Universitätsklinikum Hamburg-Eppendorf Verfahren für den nachweis karzinomatöser epithelzellen mittels freigesetzter zytokeratine als marker für diese zellen
GB0815675D0 (en) 2008-08-28 2008-10-08 Mabtech Ab Antibody secreting cell elispot
WO2012006421A2 (en) 2010-07-07 2012-01-12 The Regents Of The University Of Michigan Diagnosis and treatment of breast cancer
JP5804634B2 (ja) * 2011-10-07 2015-11-04 久和 内山 植物栽培装置
WO2014117021A2 (en) 2013-01-25 2014-07-31 Xcell Biosciences, Inc. Methods, compositions, kits, and systems for selective enrichment of target cells
FR3001805B1 (fr) 2013-02-01 2015-02-20 Biomerieux Sa Procede de detection d'un cancer colorectal
CN106244553A (zh) * 2015-10-22 2016-12-21 厦门人瑞生物医药科技有限公司 循环肿瘤细胞的分离和检测方法
FR3050212B1 (fr) 2016-04-15 2020-09-25 Chu Montpellier Procede de detection et/ou de caracterisation de cellules tumorales et appareil associe
JP2019158777A (ja) * 2018-03-16 2019-09-19 東ソー株式会社 腫瘍マーカーならびに腫瘍細胞を夾雑細胞と区別して回収および検出する方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL121659A (en) * 1996-10-25 2000-07-16 Bayer Ag Method for determining CPSA in a blood sample
US6316213B1 (en) * 1997-03-19 2001-11-13 The Board Of Trustees Of The University Of Arkansas Methods for the early diagnosis of ovarian, breast and lung cancer
KR100399475B1 (ko) * 1998-02-12 2003-09-29 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 순환 중인 암세포의 신속하고 효과적인 분리 방법 및 이를위한 제제

Also Published As

Publication number Publication date
JP2005527793A (ja) 2005-09-15
US20050079557A1 (en) 2005-04-14
WO2003076942A2 (fr) 2003-09-18
JP4256265B2 (ja) 2009-04-22
EP1506407B1 (de) 2006-06-28
DE60306517T2 (de) 2007-01-04
AU2003242815A1 (en) 2003-09-22
AU2003242815A8 (en) 2003-09-22
ES2268387T3 (es) 2007-03-16
WO2003076942A3 (fr) 2004-04-08
EP1506407A2 (de) 2005-02-16
DE60306517D1 (de) 2006-08-10

Similar Documents

Publication Publication Date Title
Mizutani et al. Expression of somatostatin receptor (SSTR) subtypes (SSTR-1, 2A, 3, 4 and 5) in neuroendocrine tumors using real-time RT-PCR method and immunohistochemistry
Schnitt Breast cancer in the 21st century: neu opportunities and neu challenges
Park et al. Comprehensive analysis of HER2 expression and gene amplification in gastric cancers using immunohistochemistry and in situ hybridization: which scoring system should we use?
ATE331958T1 (de) Verfahren zum nachweis und zur quantifizierung von -aus soliden tumoren abstammenden- zirkulierenden tumorzellen
JP2009115817A (ja) 膠芽腫の進行に関連する経路を試験するための方法及び材料
US8178307B2 (en) Methods and compositions for detection of lethal cell and uses thereof
EP1759010A2 (de) Biomarker und verfahren zur bestimmung der empfindlichkeit gegenüber modulatoren des egf(epidermal growth factor)-rezeptors
Pillai et al. Identifying biomarkers of breast cancer micrometastatic disease in bone marrow using a patient-derived xenograft mouse model
Song et al. Combined detection of HER2, Ki67, and GSTP1 genes on the diagnosis and prognosis of breast cancer
ATE545867T1 (de) I-plastin-testverfahren zur in-vitro-diagnose von kolorektalkarzinom
JP2012531612A5 (de)
CN102472753A (zh) 基于组蛋白macroH2A同工型预测癌症复发风险的诊断方法
JP2008524230A5 (de)
Wang et al. Expression of STK15 mRNA in hepatocellular carcinoma and its prognostic significance
Endo et al. HER2 mutation status in Japanese HER2-positive breast cancer patients
WO2014185528A1 (ja) Ｔｋ１タンパク質の発現が亢進した結腸直腸癌患者に対する治療効果予測方法
WO2003068268A3 (en) Treatment, diagnosis and imaging of disease
WO2009019366A3 (fr) Procede de dosage de l'aminoacylase 1 pour le diagnostic in vitro du cancer colorectal
JPWO2016143697A1 (ja) Ｓｙｔ１３、ｓｙｔ８、ａｎｏｓ１発現量による胃癌腹膜播種の検査方法、検査キット、分子標的治療薬スクリーニング方法、及び治療薬
Yau et al. HER2 overexpression of breast cancers in Hong Kong: prevalence and concordance between immunohistochemistry and in-situ hybridisation assays
JP2014505866A (ja) 甲状腺の癌様の変化を識別する方法、方法を具体化するためのキットおよび甲状腺の癌様の変化を識別するためのメタロチオネイン（ｍｔ）の使用
KR101238196B1 (ko) 대장암의 간 전이 진단용 조성물 및 그 용도
Cherciu et al. Targeted Confocal Laser Endomicroscopy (CLE) for the Assessment of Putative Cancer Stem Cell Markers in Colorectal cancer-A Pilot Study
Tanei et al. High HER2 intratumoral heterogeneity is a predictive factor for poor prognosis in Early-stage and Locally Advanced HER2-positive Breast Cancer
Wu et al. Correlation Between Drug Sensitivity Profiles of Ex Vivo Expanded Circulating Tumor Cells and Clinical Treatment Response in Pancreatic Ductal Adenocarcinoma Patients

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties